Varicella-zoster virus prophylaxis with low-dose acyclovir in patients with multiple myeloma treated with bortezomib

Warning

This publication doesn't include Faculty of Arts. It includes Faculty of Medicine. Official publication website can be found on muni.cz.
Authors

POUR Luděk ADAM Zdeněk BUREŠOVÁ Lucie KREJČÍ Marta KŘIVANOVÁ Andrea SANDECKÁ Viera ZAHRADOVÁ Lenka BÜCHLER Tomáš VORLÍČEK Jiří HÁJEK Roman

Year of publication 2009
Type Article in Periodical
Magazine / Source Clinical lymphoma & myeloma
MU Faculty or unit

Faculty of Medicine

Citation
Field Oncology and hematology
Keywords Varicella-zoster virus; acyclovir; multiple myeloma
Description Varicella-zoster virus (VZV) reactivation is a common complication in patients with multiple myeloma (MM) treated with bortezomib, with an incidence rate of 10%-60%. The aim of our study was to analyze the effect of acyclovir prophylaxis in this patient population.
Related projects:

You are running an old browser version. We recommend updating your browser to its latest version.